Lantheus Holdings (LNTH) Goodwill & Intangibles (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Goodwill & Intangibles of $1.2 billion for Q1 2026, up 447.08% year-over-year from $214.9 million in Q1 2025, and up 22.19% quarter-over-quarter from $962.3 million in Q4 2025.
Lantheus Holdings (LNTH) Goodwill & Intangibles (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Goodwill & Intangibles for 13 consecutive years, with $1.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 447.08% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 447.08% YoY), while the FY2025 annual figure was $962.3 million, up 331.62% from the prior year.
- Goodwill & Intangibles climbed to $1.2 billion in Q1 2026 per LNTH's latest filing, from $962.3 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $1.2 billion in Q3 2025 and bottomed at $101.5 million in Q2 2024.
- Historically, Goodwill & Intangibles has averaged $434.5 million across 5 years, with a median of $282.2 million in 2023.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles tumbled 64.04% — and 2026, when it surged 447.08%.
- Lantheus Holdings' Goodwill & Intangibles stood at $376.5 million in 2022, then tumbled by 43.38% to $213.2 million in 2023, then grew by 4.59% to $223.0 million in 2024, then jumped by 331.62% to $962.3 million in 2025, then grew by 22.19% to $1.2 billion in 2026.
- Business Quant data shows LNTH's Goodwill & Intangibles at $1.2 billion in Q1 2026, $962.3 million in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.18 Bn |
| Dec 31, 2025 | 962.30 Mn |
| Sep 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 536.82 Mn |
| Mar 31, 2025 | 214.93 Mn |
| Dec 31, 2024 | 222.95 Mn |
| Sep 30, 2024 | 234.80 Mn |
| Jun 30, 2024 | 101.49 Mn |
| Mar 31, 2024 | 203.24 Mn |
| Dec 31, 2023 | 213.17 Mn |
| Sep 30, 2023 | 224.48 Mn |
| Jun 30, 2023 | 282.19 Mn |
| Mar 31, 2023 | 281.05 Mn |
| Dec 31, 2022 | 376.47 Mn |
| Sep 30, 2022 | 384.78 Mn |
| Jun 30, 2022 | 393.09 Mn |
| Mar 31, 2022 | 401.39 Mn |
| Dec 31, 2021 | 409.70 Mn |
| Sep 30, 2021 | 418.07 Mn |